Kalydeco 150 MG tablet 56S

Ended Awarded Last action

Contract number
SPE2DR26FCSE2
Awardee
Awarding agency
Obligated
$38,658

Award facts

Contract value 100% obligated
$38,657.64 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

Written by GovTribe AI ·

The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 10, 2026, for Kalydeco 150 mg tablets with a ceiling value of $38,657.64, with ultimate completion by March 11, 2026.

The order is issued under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a Defense Logistics Agency indefinite delivery contract supporting firm fixed-price pharmaceutical supply to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL.

Quick answers

Who was awarded contract SPE2DR26FCSE2?

SPE2DR26FCSE2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 10, 2026.

How much is contract SPE2DR26FCSE2 worth?

The government has obligated $38,658 on SPE2DR26FCSE2.

Is contract SPE2DR26FCSE2 an order under another contract?

Yes. SPE2DR26FCSE2 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.

Was contract SPE2DR26FCSE2 competed?

The extent of competition for SPE2DR26FCSE2 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login